232 related articles for article (PubMed ID: 12700012)
21. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
23. [A case of epidermoid cyst in the intrapancreatic accessory spleen mimicking pancreatic malignant tumor].
Nakahira S; Sugimoto K; Yoshioka Y; Yoshida A; Uji K; Suzuki R; Nakata K; Miki H; Okamura S; Nakamura T; Kimura H; Hoshida Y; Tamura S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2413-5. PubMed ID: 20037440
[TBL] [Abstract][Full Text] [Related]
24. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
25. Carbohydrate antigen 19-9 producing giant epithelial cyst of the spleen in a young woman.
Terada T; Yasoshima M; Yoshimitsu Y; Nakanuma Y
J Clin Gastroenterol; 1994 Jan; 18(1):57-61. PubMed ID: 8113588
[TBL] [Abstract][Full Text] [Related]
26. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
27. Giant splenic cyst with high serum concentration of CA 19-9. Failure of treatment with percutaneous transcatheter drainage and injection of tetracycline.
Yoshikane H; Suzuki T; Yoshioka N; Ogawa Y; Hayashi Y; Hamajima E; Yokoi T
Scand J Gastroenterol; 1996 May; 31(5):524-6. PubMed ID: 8734353
[TBL] [Abstract][Full Text] [Related]
28. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
[TBL] [Abstract][Full Text] [Related]
29. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
30. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
31. Ovarian strumal carcinoid with markedly high serum levels of tumor markers.
Takemori M; Nishimura R; Sugimura K; Obayashi C; Yasuda D
Gynecol Oncol; 1995 Aug; 58(2):266-9. PubMed ID: 7622118
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
[TBL] [Abstract][Full Text] [Related]
33. [A case of hydronephrosis caused by renal stones with elevated serum levels of CA-19-9 and CA-125].
Ito S; Nishikawa K; Goto T; Tsujita M; Takegaki Y; Kishimoto T
Hinyokika Kiyo; 1994 Oct; 40(10):885-8. PubMed ID: 7992702
[TBL] [Abstract][Full Text] [Related]
34. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
35. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
36. Primary epithelial splenic cyst with micro-rupture and raised carbohydrate antigen CA 19-9: a paradigm of management.
Papadopoulos IN; Davatzikos A; Kasabalis G; Manti C; Konstantoudakis G
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791783
[TBL] [Abstract][Full Text] [Related]
37. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
Menczer J; Ben-Baruch G; Moran O; Lipitz S
Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
[TBL] [Abstract][Full Text] [Related]
38. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
[TBL] [Abstract][Full Text] [Related]
40. Atypical courses of serum tumor markers--4 case reports.
Klapdor R; Bahlo M; Babinski A
Anticancer Res; 2003; 23(2A):845-50. PubMed ID: 12820311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
